Braidwell
$2.6B Assets Reported
96 Holdings
Latest filing 2026-03-31
Top Holdings
| Ticker | Company | Shares | Value | Weight |
|---|---|---|---|---|
| CAI | CARIS LIFE SCIENCES INC | 8,009,447 | $143M | 5.5% |
| NBIX | NEUROCRINE BIOSCIENCES INC | 652,121 | $86M | 3.3% |
| GKOS | GLAUKOS CORP | 763,505 | $82M | 3.1% |
| CNTA | CENTESSA PHARMACEUTICALS PLC | 1,986,768 | $79M | 3.0% |
| XENE | XENON PHARMACEUTICALS INC | 1,338,452 | $78M | 3.0% |
| DNTH | DIANTHUS THERAPEUTICS INC | 899,364 | $75M | 2.9% |
| EWTX | EDGEWISE THERAPEUTICS INC | 2,347,583 | $74M | 2.8% |
| IRTC | IRHYTHM HOLDINGS INC | 610,192 | $72M | 2.7% |
| NUVL | NUVALENT INC | 700,429 | $72M | 2.7% |
| KOD | KODIAK SCIENCES INC | 1,818,665 | $69M | 2.6% |
Track Braidwell's 13F portfolio: $2.6B in reported holdings, 96 positions. Top holdings, AUM, and quarterly changes on SentiSense.